ConductScience.org, home

Trial · NCT01796093

Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function

NCT01796093, Completed, Cocco, Giuseppe, M.D.

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function. Trials, record NCT01796093. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01796093

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function
NCT number
NCT01796093
Status
Completed
Enrollment
42 participants, actual
Lead sponsor
Cocco, Giuseppe, M.D.
Conditions
Heart Failure, Atrial Fibrillation
Interventions
Digoxin and ivabradine
First posted
2013-02-21
Last updated
2017-02-01

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCardiac function (diastolic and systolic function)After 12-14 weeksCardiac function (echocardiography): systolic function (i.e. LVEF) and diastolic function (Doppler E/A ratio, tissue Doppler e/e1 ratio, Doppler deceleration time of the E wave.
SecondaryHeart rate and blood pressure.After 12-14 weeksChanges in heart rate and blood pressure.
SecondaryDyspnea.After 12-14.weeksChanges in dyspnea NYHA class).
SecondaryNB-proBNP valueAfter 12-14 weeksChanges (serum values) after therapy.
SecondaryBody weight12-14. weeksChanges after therapy
SecondaryLeft atrial sizeAfter 12-14 weeksChange (size).
SecondaryECGAfter 12-14 weeksChanges (heart rate,PR-interval, QRS morphology and duration), ST-T segment, other arrhythmias
SecondaryLaboratoryAfter 12-14 weeksAny changes in hematology, electrolytes, renal and hepatic function.
SecondarySide-effectsAfter 12-14 weeksAny side-effects, spontaneously reported or after specific questionining.
Secondary6-min walk testAfter 12-14 weeks.Changes in length of the walk test and heart rate during the test.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01796093

GET https://conductscience.org/api/trials/v1/NCT01796093/registered